مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

234
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

167
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

1

Information Journal Paper

Title

HIV drug resistance among naï ve HIV-infected patients in Iran

Pages

  0-0

Keywords

HIV 

Abstract

 Background: Antiretroviral (ARV) therapy extends life for persons living with HIV. Antiretroviral treatment (ART) has been rapidly expanding coverage around the world, including in Iran. However, ART Drug resistance also rapidly develops with expanding use and limits effectiveness and treatment options. The aim of this study was to monitor the appearance of new mutations conferring HIV pretreatment Drug resistance in the treatment of naï ve patients with HIV in Iran. Materials and Methods: Blood samples were obtained from ARV treatment‑ naï ve patients from 8 different provinces in Iran in 2016 for genotyping for Drug resistance mutations. Results: Sequences were successfully obtained from 90 specimens. Of these, 2 (2%) mutations conferring resistance to protease inhibitors, 2 (3%) conferring resistance to nucleoside reverse transcriptase inhibitors (NRTIs), and 9 (13%) conferring resistance to non‑ NRTI (NNRTI) were detected. Any ARV‑ resistant drug mutation was found in 11 patients (12%). Conclusion: Nearly one in 8 ARV‑ naï ve patients had mutations associated with NNRTI resistance in diverse areas of Iran in 2016. Iranian ARV therapy guideline for HIV could consider non‑ NNRTI‑ based first‑ line therapies and expand routine Drug resistance testing before treatment initiation as according to HIV Drug resistance recommendations of the World Health Organization.

Cites

References

Cite

APA: Copy

FARROKHI, MOLOOD, GHOLAMI, MOHAMMAD, MOHRAZ, MINOO, MCFARLAND, WILLI, BAESI, KAZEM, & ABBASIAN, LADAN. (2019). HIV drug resistance among naï ve HIV-infected patients in Iran. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), 24(4), 0-0. SID. https://sid.ir/paper/722322/en

Vancouver: Copy

FARROKHI MOLOOD, GHOLAMI MOHAMMAD, MOHRAZ MINOO, MCFARLAND WILLI, BAESI KAZEM, ABBASIAN LADAN. HIV drug resistance among naï ve HIV-infected patients in Iran. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS)[Internet]. 2019;24(4):0-0. Available from: https://sid.ir/paper/722322/en

IEEE: Copy

MOLOOD FARROKHI, MOHAMMAD GHOLAMI, MINOO MOHRAZ, WILLI MCFARLAND, KAZEM BAESI, and LADAN ABBASIAN, “HIV drug resistance among naï ve HIV-infected patients in Iran,” JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), vol. 24, no. 4, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/722322/en

Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button